Laura Gover, Andrew Anguko, Jane Bruce, Godfrey Magumba, et al.
1
Lee, V.
1
Lenzen, M.
1
Leon-Velarde, F.
1
Lesotho National AIDS Commission, Government of Lesotho
1
Llyod, A.
1
London School of Hygiene and Tropical Medicine
1
López, L.
1
Lucinda Ramos
1
Lukito, A.A., A.U. Rahajoe, L.I. Rilantono, et al.,
1
M. A. Babu
1
M. B. Mello
1
M. Bertram et al.
1
M. Doara, D. Choroliani, P. de Colombani
1
M. Doherty
1
M. F. Silveira
1
M. Gallardo, et al.
1
M. Holtmann
1
M. Joffres
1
M. Kan
1
M. M. Ahmmed
1
M. Odhiambo Sewe, A.M Tompkins et al.
1
M. Penazzato
1
M. Semrau
1
M. Smelyanskaya, J. Duncan
1
M. Sundararaj
1
M. Vitoria
1
M.C. Mollo, et al.
1
M.Johnson
1
M.N. Ngongondo
1
Machalaba
1
MacQuarrie, Kerry L.D., Rebecca Winter, and Sunita Kishor
1
MacQuarrie, Kerry L.D., Sarah E.K. Bradley, Alison Gemmill, and Sarah Staveteig
1
Magitta, N.F.
1
Mailloux, N.A. et al.
1
Mairie de Paris
1
Makatjane, T. J., T. Hlabana, and E. M. Letete
1
Malaria Consortium
1
Malik, A. A.
1
Mangwiro, TNC.
1
March of Dimes
1
Mark W. Rosegrant | Jawoo Koo | Nicola Cenacchi
1
Marselle M., Stadler J., Korn H., et al.
1
Martinez, L.
1
Martínez-Austria Polioptro,F and Bandala E. R
1
Mary De Silva, Lucy Lee& Grace Ryan
1
Mary-Anne Hartley, Alyssa Young, Anh-Minh Tran et al.
1
Marzouk M., Rayes D., Y. Douedari et al.
1
Massoda Tonye, S.G.
1
Matsushita, K.
1
Maurice Bucagu, Jean M. Kagubare, Paulin Basinga, Fidèle Ngabo, Barbara K Timmons & Angela C Lee
1
McCullagh S, Hunter B, Houle K et al.
1
McGahey, Christopher
1
McGloin, J.
1
MCNV, Global Initiative on Psychiatry, and World Granny
1
Mediscript Ltd
1
Melanie Duncan, et al.
1
Mensah, G.A.
1
Mental, Neurological, and Substance Use Disorders: Disease Control Priorities, Third Edition (Volume 4).
1
Meyfroidt, P.
1
Médecins Sans Frontières (MSF)
1
Médecins sans Frontières MSF
1
mhGAP
1
Michael T. Osterholma, Kristine A. Moorea, Nicholas S. Kelley et al.
1
Miller, C.
1
Ministerio de sanidad - España
1
Ministry of Health & Child Welfare
1
Ministry of Health & Family Welfare, India, et al.
1
Ministry of Health and Family Welfare Government of India
1
Ministry of Health and Family Welfare Government of the People's Republic of Bangladesh
1
Ministry of Health and Family Welfare, Directorate-General of Health Services, Mycobacterial Disease Control, National Tuberculosis Control Programme
1
Ministry of Health and Social Services (MOHSS)
1
Ministry of Health and Social Welfare, Government of India
1
Ministry of Health Ethiopia
1
Ministry of Health, Gabarone, Botswana
1
Ministry of Health, Ghana
1
Ministry of Health, Pakistan
1
Ministry of Health, Republic of South Africa
1
Ministry of Health, Republic of Uganda
1
Ministry of Health, South Africa
1
Ministry of Health, Uganda
1
Ministry of Health, Zambia
1
Ministry of Public Health, Quatar
1
Minja, N.W.
1
Mock C. N., Nugent R. et. al.
1
Mock, Charles N.
1
Mohammed A. , Putnis N. et al.
1
Monnier, N.
1
Mont, D.
1
Montelongo, A.
1
Moo-llanes, D.
1
Mortimer, K.
1
Moses, M.W.
1
MSF Access Campaign
1
MSMGF
1
Mukaratirwa, S. et al.
1
Murray, C.J.L.
1
Mutale W.
1
Myanmar Climate Change Alliance (MCCA)
1
Myanmar, Ministry of Health and Sports
1
N. Abera, T. Saballa, et al.
1
N. B. Ahmed
1
N. K. Arora
1
N.I. Agudelo Higuita, S.A. Hamer, et al.
1
NACO, Department of AIDS Control
1
Nakagaayi, D.
1
NASCOP
1
Nat Commun 13, 2788 (2022)
1
National Academy of Sciences of the USA
1
National Agency for Control of AIDS (NACA)
1
National AIDS
1
National AIDS Control Program
1
National AIDS Secretariat
1
National Department of Health South Africa
1
National HIVAIDS Council Zambia
1
National Institute of Disaster Management (NIDM), Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ)
1
National Institute of Environmental Health Sciences
1
National Malaria Elimination Centre, Ministry of Health, Zambia
1
National TB Control Programme, Bangladesh
1
Nature Communications
1
nature medicine
1
Nature Scientific Reports
1
Ncube, M.
1
ndia State-Level Disease Burden Initiative Cancer Collaborators
1
Neil M Ferguson, Daniel Laydon, Gemma Nedjati-Gilani, Natsuko Imai, Kylie Ainslie, Marc Baguelin, Sangeeta Bhatia, Adhiratha Boonyasiri, Zulma Cucunubá, Gina Cuomo-Dannenburg, Amy Dighe, Ilaria Dorigatti, Han Fu, Katy Gaythorpe, Will Green, Arran Hamlet, Wes Hinsley, Lucy C Okell, Sabine van Elsland, Hayley Thompson, Robert Verity, Erik Volz, Haowei Wang, Yuanrong Wang, Patrick GT Walker, Caroline Walters, Peter Winskill, Charles Whittaker, Christl A Donnelly, Steven Riley, Azra C Ghani.
1
Net Hope
1
Niederberger, E.
1
Norwegian Red Cross
1
Norwegian Refugee Council, Internal Displacement Monitoring Centre
1
Nouvellet, P.
1
Nove A., Friberg I., de Bernis L., et al.
1
NSW Health and University of Western Sydney
1
Nugent, Rachel
1
Nunn, Marc
1
Nunziata, K. R.
1
O. Hanssen
1
O. Samoylova
1
O. T. Ranzani
1
OECD
1
Office for the Coordination of Humanitarian Affairs OCHA
1
Oliveira, R.G. de.
1
Olney, Jack J.
1
OMS (WHO)
1
ONUSIDA
1
Organización Mundial de Saude and OPAS
1
Organização Mundial da Saúde (OMS)
1
Ouédraogo M., Samadoulougou S., Rouamba T. et. al.
The ICF Practical Manual provides information on how to use ICF. Anyone interested in learning more about use of the International Classification of Functioning, Disability and Health (ICF, WHO 2001) may benefit from reading this Practical Manual. The ICF is presently used in many different contexts... and for many different purposes around the world. It can be used as a tool for statistical, research, clinical, social policy, or educational purposes and applied, not only in the health sector, but also in sectors such as insurance, social security, labour, education, economics, policy or legislation development, and the environment. People interested in functioning and disability and seeking ways to apply the ICF should find the contents of this Practical Manual helpful. The Practical Manual provides a range of information on how to apply ICF in various situations. It is built on the acquired expertise, knowledge and judgement of users in their respective areas of work, and is designed to be used alongside the ICF itself, which remains the primary reference. more
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...st issued 8 January 2021, updated 15 June 2021, updated 19 November 2021, updated 21 January 2022, updated 18 August 2022. Available in other languages https://apps.who.int/iris/handle/10665/361720more
Energy use in the home is a vital and ubiquitous feature of human society. Energy
is used for a wide variety of purposes, including cooking, space heating, light-
ing, small-scale income generation, various household tasks, and entertainment.
The threat posed by Zika virus infection highlights the need to reinforce preparedness arrangements for mosquito-borne diseases in EU/EEA countries, especially for pathogens transmitted by Aedes aegypti and Aedes albopictus.
The aim of this document is to highlight measures that can effectively red...uce the risk of importation and local transmission of pathogens transmitted by Ae. aegypti and Ae. albopictus. The main diseases of concern in this context are Zika, dengue, chikungunya and yellow fever.more
This progress report reviews recent gains, new developments and remaining challenges as countries approach the 2020 targets of the Start Free Stay Free AIDS Free framework.
This new guidance aims to support programme implementers, coordinators and others in humanitarian settings in their actions to counter suicide and self-harm in humanitarian contexts and to save lives.
The goals and objectives of the Sudan National Action Plan on AMR can only be achieved through implementing strategic interventions and activities with all concerned ministries and departments joining hands with other stakeholders to collaboratively tackle these challenges.
The Committee discussed the implications for preparedness for smallpox-like events reflected by the ongoing COVID-19 pandemic. The Committee noted how quickly diagnostics and vaccines could be developed and deployed when resources and political will were abundant. This rapidity was also due to the f...act that the genetic sequence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had been shared worldwide. It was noted that in one country SARS-CoV-2 had been reconstructed in a laboratory from the viral genome sequence before the first case of COVID-19 had been reported, highlighting the benefits of synthetic biology technologies for accelerated development of diagnostics as well as the oft-described potential risks. Lessons learned about clinical care during the COVID-19 pandemic were also discussed.more